Development and validation of the HPLC-procedure for the quantitative determination of isosorbide dinitrate in matrix granules

Authors

  • D. S. Oleynikov RPF “MICROKHIM” LTD, Ukraine
  • A. G. Kaplaushenko Zaporizhzhia State Medical University, Ukraine

DOI:

https://doi.org/10.24959/ophcj.19.174771

Keywords:

isosorbide dinitrate, high performance liquid chromatography, validation

Abstract

Isosorbide dinitrate is a universally recognized drug for the relief of angina attacks. Today, prolonged forms of isosorbide dinitrate are of great interest due to their high antianginal efficacy and lower frequency of side effects that are characteristic for drugs with immediate release.
Aim. To develop the procedure for the quantitative determination of isosorbide dinitrate in matrix granules using high performance liquid chromatography and validate it.
Results. To determine isosorbide dinitrate by the method of high performance liquid chromatography with UV-detection the optimal chromatographic conditions were selected taking into account the effect of excipients in the composition of the medicine. To prove the possibility of applying the procedure proposed in the further analysis of matrix granules of isosorbide dinitrate its validation was carried out. Such validation parameters as specificity, linearity, repeatability, accuracy, intermediate precision, limit of detection and limit of quantification, robustness were assessed using model solutions.
Experimental part. The chromatographic researches were performed using liquid chromatograph Shimadzu LC-20AD XR with diode-array detector under the following conditions: chromatographic column – Supelco Discovery C18 (150 × 4.6 мм, 5 мкм); mobile phase – water R – buffer solution with (pH 4.7) – methanol R2 (35:10:55); elution mode – isocratic; flow rate of the mobile phase – 1.0 mL/min.; detection wavelength –220 nm; software – LCsolution, 1.24.SP.1 version.
Conclusions. A new procedure for the quantitative determination of isosorbide dinitrate in matrix granules has been developed using high performance liquid chromatography. Its validation has been carried out, and its acceptability has been proven.

Supporting Agencies

  • RPF “MICROKHIM” LTD
  • Ukraine

Downloads

Download data is not yet available.

References

  1. Zhiljaev, E. V. (2010). Сonsilium Medicum, 12(1), 14–18.
  2. Lupanov, V. P. (2009). Spravochnik poliklinicheskogo vracha, 9, 13–19.
  3. Tereshchenko, S. N., Zhirov, I. V. (2009). Serdtce, 8(1), 9–11.
  4. Münzel, T., Daiber, A., Gori, T. (2011). Nitrate Therapy. Circulation, 123(19), 2132–2144. https://doi.org/10.1161/circulationaha.110.981407
  5. Oliinykov, D. S., Kaplaushenko, A. H. (2019). [Substantiation of manufacture technology development for the tablets of isosorbide dinitrate with modified release]. Current Issues in Pharmacy and Medicine: Science and Practice, 12 (2), 160–165. https://doi.org/10.14739/2409-2932.2019.2.170982
  6. Ruban, E. A., Khokhlova, L. N., Bobritckaia, L. A., Spiridonov, S. V. (2016). Sovremennye napravleniia v tekhnologii tverdykh lekarstvennykh sredstv. Kharkiv: NFaU, 88.
  7. Lee, P. I., Li, J.-X. (2010). Evolution of Oral Controlled Release Dosage Forms. Oral Controlled Release Formulation Design and Drug Delivery, 21–31. https://doi.org/10.1002/9780470640487.ch2
  8. Wani, M. S., Polshettiwar, S. A., Chopade, V. V., Joshi, R. N., Dehghan, M. H. G., Gadkari, A. A., Chepurwar, S., Mute, V. (2008). Controlled Release System A Review. Pharmaceutical Reviews, 6(1), 41–46.
  9. Mogiliuk, V. (2014). Farmatcevticheskaia otrasl, 2(43), 36–39.
  10. Roy, P., Shahiwala, A. (2009). Multiparticulate formulation approach to pulsatile drug delivery: Current perspectives. Journal of Controlled Release, 134(2), 74–80. https://doi.org/10.1016/j.jconrel.2008.11.011
  11. Grizodub, A. I. (2016). Standartizovannye protcedury validatcii metodik kontrolia kachestva lekarstvennykh sredstv. Kharkiv: DP «Ukrainskii naukovii farmakopeinii tcentr yakosti likarskikh zasobiv», 396.
  12. CPMP/ICH/381/95 Q2(R1) Validation of Analytical Procedures : Text and Methodology. (1995). Available at: https://www.ema.europa.eu/en/documents/scientific-guideline/ich-q-2-r1-validation-analytical-procedures-text-methodology-step-5_en.pdf
  13. Derzhavna farmakopeia Ukrainy. (2015). Vols. 1–3. Vol. 1. 2nd ed. Derzhavne pidpryiemstvo «Ukrainskyi naukovyi ekspertnyi farmakopeinyi tsentr yakosti likarskykh zasobiv». Kharkiv, 1128.

Downloads

Published

2019-09-03

How to Cite

(1)
Oleynikov, D. S.; Kaplaushenko, A. G. Development and Validation of the HPLC-Procedure for the Quantitative Determination of Isosorbide Dinitrate in Matrix Granules. J. Org. Pharm. Chem. 2019, 17, 51-58.

Issue

Vol. 17 No. 3(67) (2019)

Section

Original Researches

License

Copyright (c) 2019 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors publishing their works in the Journal of Organic and Pharmaceutical Chemistry agree with the following terms:

1. Authors retain copyright and grant the journal the right of the first publication of the work under Creative Commons Attribution License allowing everyone to distribute and re-use the published material if proper citation of the original publication is given.

2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book) providing proper citation of the original publication.

3. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on authors’ personal websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).